4//SEC Filing
Wallace Max N. 4
Accession 0001818382-22-000093
CIK 0001818382other
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 4:22 PM ET
Size
5.4 KB
Accession
0001818382-22-000093
Insider Transaction Report
Form 4
Humacyte, Inc.HUMA
Wallace Max N.
Director
Transactions
- Award
Stock Options (right to buy)
2022-06-09+8,500→ 8,500 totalExercise: $4.34Exp: 2032-06-09→ Common Stock (8,500 underlying)
Footnotes (1)
- [F1]The first 25% of the option becomes exercisable on June 9, 2023, after which 1/48 of the option will become exercisable on the 9th of each month through June 9, 2026.
Documents
Issuer
Humacyte, Inc.
CIK 0001818382
Entity typeother
Related Parties
1- filerCIK 0001877453
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 4:22 PM ET
- Size
- 5.4 KB